Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 Apr;50(4):415–421. doi: 10.1136/thx.50.4.415

New strategies for treatment of pulmonary fibrosis.

S H Phan 1
PMCID: PMC474300  PMID: 7785018

Full text

PDF
415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alton E. W., Johnson M., Turner-Warwick M. Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A. Respir Med. 1989 Jul;83(4):277–279. doi: 10.1016/s0954-6111(89)80196-9. [DOI] [PubMed] [Google Scholar]
  2. Arend W. P. Interleukin-1 receptor antagonist. Adv Immunol. 1993;54:167–227. doi: 10.1016/s0065-2776(08)60535-0. [DOI] [PubMed] [Google Scholar]
  3. Aycock R. S., Raghow R., Stricklin G. P., Seyer J. M., Kang A. H. Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem. 1986 Oct 25;261(30):14355–14360. [PubMed] [Google Scholar]
  4. Benbernou N., Matsiota-Bernard P., Guenounou M. Antisense oligonucleotides to interleukin-4 regulate IgE and IgG2a production by spleen cells from Nippostrongylus brasiliensis-infected rats. Eur J Immunol. 1993 Mar;23(3):659–663. doi: 10.1002/eji.1830230313. [DOI] [PubMed] [Google Scholar]
  5. Beno D. W., Espinal R., Edelstein B. M., Davis B. H. Administration of prostaglandin E1 analog reduces rat hepatic and Ito cell collagen gene expression and collagen accumulation after bile duct ligation injury. Hepatology. 1993 Apr;17(4):707–714. doi: 10.1002/hep.1840170427. [DOI] [PubMed] [Google Scholar]
  6. Border W. A., Noble N. A., Yamamoto T., Tomooka S., Kagami S. Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int. 1992 Mar;41(3):566–570. doi: 10.1038/ki.1992.83. [DOI] [PubMed] [Google Scholar]
  7. Border W. A., Okuda S., Languino L. R., Sporn M. B., Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 1990 Jul 26;346(6282):371–374. doi: 10.1038/346371a0. [DOI] [PubMed] [Google Scholar]
  8. Brigham K. L., Meyrick B., Christman B., Conary J. T., King G., Berry L. C., Jr, Magnuson M. A. Expression of human growth hormone fusion genes in cultured lung endothelial cells and in the lungs of mice. Am J Respir Cell Mol Biol. 1993 Feb;8(2):209–213. doi: 10.1165/ajrcmb/8.2.209. [DOI] [PubMed] [Google Scholar]
  9. Broekelmann T. J., Limper A. H., Colby T. V., McDonald J. A. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6642–6646. doi: 10.1073/pnas.88.15.6642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cantin A. M., Boileau R., Bégin R. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1988 Mar;137(3):572–578. doi: 10.1164/ajrccm/137.3.572. [DOI] [PubMed] [Google Scholar]
  11. Chandler D. B., Butler T. W., Briggs D. D., 3rd, Grizzle W. E., Barton J. C., Fulmer J. D. Modulation of the development of bleomycin-induced fibrosis by deferoxamine. Toxicol Appl Pharmacol. 1988 Mar 15;92(3):358–367. doi: 10.1016/0041-008x(88)90176-7. [DOI] [PubMed] [Google Scholar]
  12. Clark J. G., Dedon T. F., Wayner E. A., Carter W. G. Effects of interferon-gamma on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts. J Clin Invest. 1989 May;83(5):1505–1511. doi: 10.1172/JCI114045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Conacher I. D., Dark J., Hilton C. J., Corris P. Isolated lung transplantation for pulmonary fibrosis. Anaesthesia. 1990 Nov;45(11):971–975. doi: 10.1111/j.1365-2044.1990.tb14635.x. [DOI] [PubMed] [Google Scholar]
  14. Crookston K. P., Webb D. J., Lamarre J., Gonias S. L. Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations. Biochem J. 1993 Jul 15;293(Pt 2):443–450. doi: 10.1042/bj2930443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cross C. E., Warren D., Gerriets J. E., Wilson D. W., Halliwell B., Last J. A. Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats. J Lab Clin Med. 1985 Oct;106(4):433–438. [PubMed] [Google Scholar]
  16. Danielpour D., Sporn M. B. Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin. J Biol Chem. 1990 Apr 25;265(12):6973–6977. [PubMed] [Google Scholar]
  17. Denis M., Cormier Y., Laviolette M. Murine hypersensitivity pneumonitis: a study of cellular infiltrates and cytokine production and its modulation by cyclosporin A. Am J Respir Cell Mol Biol. 1992 Jan;6(1):68–74. doi: 10.1165/ajrcmb/6.1.68. [DOI] [PubMed] [Google Scholar]
  18. Dunn D. L. Use of novel therapeutic agents for the treatment of serious infection. Am J Surg. 1993 Nov;166(5):449–455. doi: 10.1016/s0002-9610(05)81141-9. [DOI] [PubMed] [Google Scholar]
  19. Elias J. A., Freundlich B., Kern J. A., Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest. 1990 Jun;97(6):1439–1445. doi: 10.1378/chest.97.6.1439. [DOI] [PubMed] [Google Scholar]
  20. Fort J. G., Scovern H., Abruzzo J. L. Intravenous cyclophosphamide and methylprednisolone for the treatment of bronchiolitis obliterans and interstitial fibrosis associated with crysotherapy. J Rheumatol. 1988;15(5):850–854. [PubMed] [Google Scholar]
  21. Fukazawa M., Kawano M., Hisano S., Ueda K., Matsuba K. Efficacy of cyclosporin A for idiopathic pulmonary fibrosis. Eur J Pediatr. 1990 Mar;149(6):441–442. doi: 10.1007/BF02009669. [DOI] [PubMed] [Google Scholar]
  22. Gauldie J., Jordana M., Cox G. Cytokines and pulmonary fibrosis. Thorax. 1993 Sep;48(9):931–935. doi: 10.1136/thx.48.9.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Giri S. N., Hyde D. M. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence. Am J Pathol. 1988 Dec;133(3):525–536. [PMC free article] [PubMed] [Google Scholar]
  24. Giri S. N., Hyde D. M. Increases in severity of lung damage and mortality by treatment with cyclo and lipoxygenase inhibitors in bleomycin and hyperoxia model of lung injury in hamsters. Pathology. 1987 Apr;19(2):150–158. doi: 10.3109/00313028709077126. [DOI] [PubMed] [Google Scholar]
  25. Grossman R. F., Frost A., Zamel N., Patterson G. A., Cooper J. D., Myron P. R., Dear C. L., Maurer J. Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med. 1990 Mar 15;322(11):727–733. doi: 10.1056/NEJM199003153221104. [DOI] [PubMed] [Google Scholar]
  26. Hein R., Behr J., Hündgen M., Hunzelmann N., Meurer M., Braun-Falco O., Urbanski A., Krieg T. Treatment of systemic sclerosis with gamma-interferon. Br J Dermatol. 1992 May;126(5):496–501. doi: 10.1111/j.1365-2133.1992.tb11824.x. [DOI] [PubMed] [Google Scholar]
  27. Hoyt D. G., Lazo J. S. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther. 1988 Aug;246(2):765–771. [PubMed] [Google Scholar]
  28. Hyde D. M., Henderson T. S., Giri S. N., Tyler N. K., Stovall M. Y. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res. 1988;14(5):687–704. doi: 10.3109/01902148809087837. [DOI] [PubMed] [Google Scholar]
  29. Ikeda H., Wu G. Y., Wu C. H. Lipocytes from fibrotic rat liver have an impaired feedback response to procollagen propeptides. Am J Physiol. 1993 Jan;264(1 Pt 1):G157–G162. doi: 10.1152/ajpgi.1993.264.1.G157. [DOI] [PubMed] [Google Scholar]
  30. Itoh H., Mukoyama M., Pratt R. E., Dzau V. J. Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide. Biochem Biophys Res Commun. 1992 Nov 16;188(3):1205–1213. doi: 10.1016/0006-291x(92)91359-x. [DOI] [PubMed] [Google Scholar]
  31. Jamieson D. D., Kerr D. R., Unsworth I. Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice. Lung. 1987;165(4):239–247. doi: 10.1007/BF02714441. [DOI] [PubMed] [Google Scholar]
  32. Janssen Y. M., Engelen J. J., Giancola M. S., Low R. B., Vacek P., Borm P. J. Serum type III procollagen N-terminal peptide in coal miners. Exp Lung Res. 1992 Jan-Mar;18(1):1–8. doi: 10.3109/01902149209020646. [DOI] [PubMed] [Google Scholar]
  33. Johnson M. A., Kwan S., Snell N. J., Nunn A. J., Darbyshire J. H., Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 1989 Apr;44(4):280–288. doi: 10.1136/thx.44.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Katayama K., Seyer J. M., Raghow R., Kang A. H. Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide. Biochemistry. 1991 Jul 23;30(29):7097–7104. doi: 10.1021/bi00243a009. [DOI] [PubMed] [Google Scholar]
  35. Kelley J. Cytokines of the lung. Am Rev Respir Dis. 1990 Mar;141(3):765–788. doi: 10.1164/ajrccm/141.3.765. [DOI] [PubMed] [Google Scholar]
  36. Khalil N., Bereznay O., Sporn M., Greenberg A. H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med. 1989 Sep 1;170(3):727–737. doi: 10.1084/jem.170.3.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kulkarni A. B., Huh C. G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M., Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770–774. doi: 10.1073/pnas.90.2.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kunkel S. L., Spengler M., May M. A., Spengler R., Larrick J., Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988 Apr 15;263(11):5380–5384. [PubMed] [Google Scholar]
  39. Maini R. N., Brennan F. M., Williams R., Chu C. Q., Cope A. P., Gibbons D., Elliott M., Feldmann M. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy. Clin Exp Rheumatol. 1993 Mar-Apr;11 (Suppl 8):S173–S175. [PubMed] [Google Scholar]
  40. Mancini J. A., Prasit P., Coppolino M. G., Charleson P., Leger S., Evans J. F., Gillard J. W., Vickers P. J. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors. Mol Pharmacol. 1992 Feb;41(2):267–272. [PubMed] [Google Scholar]
  41. Massagué J. Receptors for the TGF-beta family. Cell. 1992 Jun 26;69(7):1067–1070. doi: 10.1016/0092-8674(92)90627-o. [DOI] [PubMed] [Google Scholar]
  42. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;6:597–641. doi: 10.1146/annurev.cb.06.110190.003121. [DOI] [PubMed] [Google Scholar]
  43. Mastrangeli A., Danel C., Rosenfeld M. A., Stratford-Perricaudet L., Perricaudet M., Pavirani A., Lecocq J. P., Crystal R. G. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest. 1993 Jan;91(1):225–234. doi: 10.1172/JCI116175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Mohler K. M., Torrance D. S., Smith C. A., Goodwin R. G., Stremler K. E., Fung V. P., Madani H., Widmer M. B. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol. 1993 Aug 1;151(3):1548–1561. [PubMed] [Google Scholar]
  45. Molteni A., Ward W. F., Ts'ao C. H., Solliday N. H., Dunne M. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc Soc Exp Biol Med. 1985 Oct;180(1):112–120. doi: 10.3181/00379727-180-42151. [DOI] [PubMed] [Google Scholar]
  46. Moolman J. A., Bardin P. G., Rossouw D. J., Joubert J. R. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax. 1991 Aug;46(8):592–595. doi: 10.1136/thx.46.8.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mossman B. T., Marsh J. P., Sesko A., Hill S., Shatos M. A., Doherty J., Petruska J., Adler K. B., Hemenway D., Mickey R. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1266–1271. doi: 10.1164/ajrccm/141.5_Pt_1.1266. [DOI] [PubMed] [Google Scholar]
  48. Nagai A., Aoshiba K., Ishihara Y., Inano H., Sakamoto K., Yamaguchi E., Kagawa J., Takizawa T. Administration of alpha 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis. 1992 Mar;145(3):651–656. doi: 10.1164/ajrccm/145.3.651. [DOI] [PubMed] [Google Scholar]
  49. Nagaoka I., Trapnell B. C., Crystal R. G. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest. 1990 Jun;85(6):2023–2027. doi: 10.1172/JCI114669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Nakashima J. M., Hyde D. M., Giri S. N. Effects of a calmodulin inhibitor on bleomycin-induced lung inflammation in hamsters. Biochemical, morphometric, and bronchoalveolar lavage data. Am J Pathol. 1986 Sep;124(3):528–536. [PMC free article] [PubMed] [Google Scholar]
  51. Okada T., Sugie I., Aisaka K. Effects of gamma-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats. Lymphokine Cytokine Res. 1993 Apr;12(2):87–91. [PubMed] [Google Scholar]
  52. Parizada B., Werber M. M., Nimrod A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun. 1991;15(5):297–301. doi: 10.3109/10715769109105225. [DOI] [PubMed] [Google Scholar]
  53. Phan S. H., Gannon D. E., Varani J., Ryan U. S., Ward P. A. Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol. 1989 Jun;134(6):1201–1211. [PMC free article] [PubMed] [Google Scholar]
  54. Phan S. H., Gannon D. E., Varani J., Ryan U. S., Ward P. A. Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol. 1989 Jun;134(6):1201–1211. [PMC free article] [PubMed] [Google Scholar]
  55. Phan S. H., Gannon D. E., Ward P. A., Karmiol S. Mechanism of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: evidence of a role for elastase. Am J Respir Cell Mol Biol. 1992 Mar;6(3):270–278. doi: 10.1165/ajrcmb/6.3.270. [DOI] [PubMed] [Google Scholar]
  56. Phan S. H., Gharaee-Kermani M., McGarry B., Kunkel S. L., Wolber F. W. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha. J Immunol. 1992 Jul 1;149(1):103–106. [PubMed] [Google Scholar]
  57. Phan S. H., Gharaee-Kermani M., Wolber F., Ryan U. S. Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin. J Clin Invest. 1991 Jan;87(1):148–154. doi: 10.1172/JCI114964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Phan S. H., Kunkel S. L. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production. Am J Pathol. 1986 Aug;124(2):343–352. [PMC free article] [PubMed] [Google Scholar]
  59. Phan S. H., Kunkel S. L. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res. 1992 Jan-Mar;18(1):29–43. doi: 10.3109/01902149209020649. [DOI] [PubMed] [Google Scholar]
  60. Phan S. H., McGarry B. M., Loeffler K. M., Kunkel S. L. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry. 1988 Apr 19;27(8):2846–2853. doi: 10.1021/bi00408a028. [DOI] [PubMed] [Google Scholar]
  61. Phan S. H., McGarry B. M., Loeffler K. M., Kunkel S. L. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites. J Leukoc Biol. 1987 Aug;42(2):106–113. doi: 10.1002/jlb.42.2.106. [DOI] [PubMed] [Google Scholar]
  62. Phan S. H., Thrall R. S. Inhibition of bleomycin-induced pulmonary fibrosis by cobra venom factor. Am J Pathol. 1982 Apr;107(1):25–28. [PMC free article] [PubMed] [Google Scholar]
  63. Piguet P. F., Collart M. A., Grau G. E., Kapanci Y., Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med. 1989 Sep 1;170(3):655–663. doi: 10.1084/jem.170.3.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Piguet P. F., Rosen H., Vesin C., Grau G. E. Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Respir Dis. 1993 Feb;147(2):435–441. doi: 10.1164/ajrccm/147.2.435. [DOI] [PubMed] [Google Scholar]
  65. Piguet P. F., Vesin C., Grau G. E., Thompson R. C. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine. 1993 Jan;5(1):57–61. doi: 10.1016/1043-4666(93)90024-y. [DOI] [PubMed] [Google Scholar]
  66. Päkkö P., Sormunen R., Risteli L., Risteli J., Ala-Kokko L., Ryhänen L. Malotilate prevents accumulation of type III pN-collagen, type IV collagen, and laminin in carbon tetrachloride-induced pulmonary fibrosis in rats. Am Rev Respir Dis. 1989 May;139(5):1105–1111. doi: 10.1164/ajrccm/139.5.1105. [DOI] [PubMed] [Google Scholar]
  67. Raghow B., Irish P., Kang A. H. Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest. 1989 Dec;84(6):1836–1842. doi: 10.1172/JCI114369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Rolfe M. W., Kunkel S. L., Standiford T. J., Chensue S. W., Allen R. M., Evanoff H. L., Phan S. H., Strieter R. M. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol. 1991 Nov;5(5):493–501. doi: 10.1165/ajrcmb/5.5.493. [DOI] [PubMed] [Google Scholar]
  69. Rom W. N., Basset P., Fells G. A., Nukiwa T., Trapnell B. C., Crysal R. G. Alveolar macrophages release an insulin-like growth factor I-type molecule. J Clin Invest. 1988 Nov;82(5):1685–1693. doi: 10.1172/JCI113781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Rosenbloom J., Feldman G., Freundlich B., Jimenez S. A. Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem Biophys Res Commun. 1984 Aug 30;123(1):365–372. doi: 10.1016/0006-291x(84)90422-4. [DOI] [PubMed] [Google Scholar]
  71. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991 Aug;10(8):2247–2258. doi: 10.1002/j.1460-2075.1991.tb07761.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Segal G. M., Smith T. D., Heinrich M. C., Ey F. S., Bagby G. C., Jr Specific repression of granulocyte-macrophage and granulocyte colony-stimulating factor gene expression in interleukin-1-stimulated endothelial cells with antisense oligodeoxynucleotides. Blood. 1992 Aug 1;80(3):609–616. [PubMed] [Google Scholar]
  73. Sendelbach L. E., Lindenschmidt R. C., Witschi H. P. The effect of cyclosporin A on pulmonary fibrosis induced by butylated hydroxytoluene, bleomycin and beryllium sulfate. Toxicol Lett. 1985 Aug;26(2-3):169–173. doi: 10.1016/0378-4274(85)90162-6. [DOI] [PubMed] [Google Scholar]
  74. Shahzeidi S., Sarnstrand B., Jeffery P. K., McAnulty R. J., Laurent G. J. Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J. 1991 Jul;4(7):845–852. [PubMed] [Google Scholar]
  75. Sheppard M. N., Harrison N. K. New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax. 1992 Dec;47(12):1064–1074. doi: 10.1136/thx.47.12.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992 Oct 22;359(6397):693–699. doi: 10.1038/359693a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Standiford T. J., Kunkel S. L., Phan S. H., Rollins B. J., Strieter R. M. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 1991 May 25;266(15):9912–9918. [PubMed] [Google Scholar]
  78. Strieter R. M., Lukacs N. W., Standiford T. J., Kunkel S. L. Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. Thorax. 1993 Jul;48(7):765–769. doi: 10.1136/thx.48.7.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Tetley T. D. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax. 1993 May;48(5):560–565. doi: 10.1136/thx.48.5.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Wang Q. J., Giri S. N., Hyde D. M., Li C. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol. 1991 Aug 8;42(5):1115–1122. [PubMed] [Google Scholar]
  81. Ward W. F., Molteni A., Ts'ao C. H., Kim Y. T., Hinz J. M. Radiation pneumotoxicity in rats: modification by inhibitors of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys. 1992;22(3):623–625. doi: 10.1016/0360-3016(92)90890-t. [DOI] [PubMed] [Google Scholar]
  82. Wherry J. C., Pennington J. E., Wenzel R. P. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies. Crit Care Med. 1993 Oct;21(10 Suppl):S436–S440. doi: 10.1097/00003246-199310001-00004. [DOI] [PubMed] [Google Scholar]
  83. Yoshimura K., Rosenfeld M. A., Nakamura H., Scherer E. M., Pavirani A., Lecocq J. P., Crystal R. G. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res. 1992 Jun 25;20(12):3233–3240. doi: 10.1093/nar/20.12.3233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. al-Janadi M., Smith C. D., Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol. 1989 Dec;16(12):1592–1596. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES